GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: Ai Xin'an® (China) | SHR-1209 | SHR1209
recaticimab is an approved drug
Compound class:
Antibody
Comment: Recaticimab (SHR-1209) is an anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibody.
|
Classification ![]() |
|
Compound class | Antibody |
Approved drug? | Yes. China NMPA (2025) |
International Nonproprietary Names ![]() |
|
INN number | INN |
11502 | recaticimab |
Synonyms ![]() |
Ai Xin'an® (China) | SHR-1209 | SHR1209 |
Database Links ![]() |
|
Search PubMed clinical trials | recaticimab |
Search PubMed titles | recaticimab |
Search PubMed titles/abstracts | recaticimab |